Objectives: As life expectancy of people living with HIV (PLWH) improves in lowincome and middle-income countries (LMICs), the spectrum of HIV-related pulmonary complications may reflect a greater burden of chronic lung diseases as in high-income countries. We determined whether the risk of abnormal spirometry was greater among adolescent compared with adult PLWH at the Coptic Hope Center for Infectious Diseases in Nairobi, Kenya, and evaluated the role of other cofactors for abnormal spirometry.
Introduction
Of the 37 million people living with HIV (PLWH), 26 million live in sub-Saharan Africa, including greater than 3 million children and adolescents [1] . With increasing access to antiretroviral therapy (ART), PLWH experience longer life expectancies worldwide, and chronic noncommunicable diseases are increasingly prevalent [2] . Although pulmonary infections remain important contributors to morbidity and mortality in low and middleincome countries (LMICs) [3] , the spectrum of HIVrelated pulmonary complications may reflect a greater burden of chronic lung diseases (CLD) as in high-income countries [4, 5] .
Emerging data from cohorts of PLWH in sub-Saharan Africa report a substantial prevalence of abnormal spirometry, a manifestation of CLD. Prevalence estimates for abnormal spirometry are as high as 45%, and vary by age, region, smoking, biofuel exposure, and ART use. Although abnormal spirometry prevalence among adults ranges from 2 to 35% [6] [7] [8] [9] [10] , a striking 24-45% prevalence of abnormal spirometry is reported among sub-Saharan African adolescents living with HIV [11] [12] [13] [14] [15] . As none of these cohorts enrolled both adolescents and adults, it remains unknown whether adolescents are truly at greater risk of abnormal lung function compared with adults, and if heterogeneity in exposures accounts for these apparent age-related differences in prevalence.
In this study, we determined whether the risk of abnormal spirometry was greater among adolescent compared with adult PLWH receiving routine care at the Coptic Hope Center for Infectious Diseases in Nairobi, Kenya, and evaluated the role of other cofactors for abnormal spirometry.
Some results of this study have been reported as an abstract [16] .
Methods
Expanded methods are in the Supplemental Digital Content (SDC, http://links.lww.com/QAD/B270).
Study design and cohort
Adolescent (10-19 years) and adult (!20 years) PLWH, receiving routine care at the Nairobi-based Hope Center (January-March 2014) were prospectively enrolled for this cross-sectional analysis. The Hope Center provides free ART and comprehensive care to PLWH in a primarily poor, urban area [17] . Individuals with acute respiratory infections, recent tuberculosis, or pregnancy were excluded. All participants provided their written informed consent/assent. Ethics approvals were obtained from Kenyatta National Hospital/University of Nairobi and University of Washington.
Clinical assessment
Standardized questionnaires assessed risk factors/exposures, including smoking and indoor combustible fuel use. HIV-related variables were abstracted from Hope Center databases. Recent CD4 þ preceded study visits by 120 days or less. World Health Organization (WHO) Clinical HIV Stage was determined at Hope Center enrollment. Adolescents who reported maternal/sibling HIV infection, no sexual debut, and no injection drug use met criteria for perinatally acquired HIV.
Oxygen saturation was measured at rest and after submaximal exercise. Low BMI was defined as BMI less than 18.5 kg/m 2 for adults and BMI-for-age z score less than À2 for adolescents [18] .
Spirometry
Forced expiratory volume in 1 s (FEV 1 ) and forced vital capacity (FVC) were measured before and 15 min after administration of 400 mg salbutamol via LiteAire spacer according to American Thoracic Society standards using an ndd EasyOne spirometer (ndd Medizintechnik AG, Zurich, Switzerland) [19] .
Global Lung Initiative equations were used to determine predicted FEV 1 and FVC, FEV 1 /FVC less than lower limit of normal (<LLN), FEV 1 less than LLN and FVC less than LLN [20] . We defined airflow limitation as FEV 1 /FVC less than LLN. We considered spirometry as abnormal if any of these patterns was present prebronchodilator to allow comparison with studies that have not uniformly administered bronchodilators. Bronchodilator responsiveness was identified if postbronchodilator FEV 1 or FVC increased 200 ml and 12% among adults and if FEV 1 increased greater than 10% among adolescents [21, 22] .
Chest computed tomography scans
Given the prevalence of respiratory abnormalities among adolescents, we obtained noncontrast high-resolution chest computed tomography (CT) in adolescents who consented/assented. Scans were interpreted by a boardcertified radiologist with expertise in thoracic radiology blinded to clinical data.
Statistical analysis
Characteristics were compared by age group and abnormal spirometry, using x 2 or Fisher's exact tests for categorical, t tests with unequal variance for spirometry and Wilcoxon rank-sum tests for other continuous variables.
Bivariate logistic regression evaluated associations of adolescent age and cofactors that we hypothesized a priori would be associated with abnormal spirometry (CD4 þ <200, WHO HIV Stage 3/4, ART, low BMI, combustible fuel use, cigarette smoking, and prior pulmonary infections). We compared any abnormal versus normal spirometry, and individual abnormal patterns versus normal (SDC Table S1 , http://links.lww.com/QAD/ B270). To avoid overfitting adjusted models that determined associations between adolescent age and abnormal spirometry, cofactors were retained if they did not co-vary or if they had substantive effects on other variables. We determined correlations between spirometry and CT findings among adolescents. Analyses were performed using Stata, version 14.1 (College Station, Texas, USA).
Results
Clinical characteristics by age group Median age was 13 years among 52 adolescents and 40 years among 375 adults; 54% of adolescents were male compared with 33% of adults ( Table 1 , SDC Figure S1 , http://links.lww.com/QAD/B270). No adolescents smoked, and there was no difference in prevalence of indoor combustible fuel burning. BMI was low in 23% of adolescents compared with 5% of adults. Nearly all adolescents met criteria for perinatally acquired HIV. Compared with 55% of adults, only 25% of adolescents had nadir CD4 þ less than 200 cells/ml; 7% of adolescents had recent CD4 þ <200. Adolescents had nearly universal ART and co-trimoxazole use. Yet, compared with adults, adolescents had a significantly higher prevalence of respiratory symptoms and oxygen saturation 92% or less, especially after sub-maximal exercise.
Spirometry outcomes
Substantially more adolescents had abnormal spirometry compared with adults (40 vs. 17%, P < 0.001; Table 2 ).
Airflow limitation was present in 23% of adolescents and 10% of adults prebronchodilator (P ¼ 0.008), and in 27 and 7% postbronchodilator, respectively (P < 0.001). Among adolescents and adults with prebronchodilator airflow limitation, 50 and 74% had persistent airflow limitation after bronchodilator, respectively. Overall bronchodilator responsiveness was similar among adolescents and adults. Adolescents had a significantly higher prevalence of FEV 1 less than LLN and FVC less than LLN.
Cofactors for abnormal spirometry Participants with abnormal spirometry were more likely to be adolescents compared with those with normal spirometry (25 vs. 9%, P < 0.001; Table 1 ). Smoking status did not differ by spirometry, even when restricted to adults. Smokers with abnormal spirometry reported greater pack-years (P ¼ 0.06). Participants with abnormal spirometry were more likely to use kerosene, and have prior pulmonary tuberculosis, obstructive CLD diagnoses, low BMI and respiratory symptoms compared with those with normal spirometry.
Independent risk for abnormal spirometry patterns
In multivariable analysis, adolescent age (adjusted odds ratio 3.22; 95% confidence interval 1.48-6.98), prior pulmonary tuberculosis (3.15; 1.70-5.58), kerosene use (1.77; 1.04-3.04) and smoking pack-years (1.05; 1.00-1.10) were associated with abnormal spirometry (SDC Table S2 , http://links.lww.com/QAD/B270). Adolescent age, prior tuberculosis, and pack-years were associated with airflow limitation. Kerosene use and prior tuberculosis were associated with FEV 1 less than LLN. Prior tuberculosis and low BMI were associated with FVC less than LLN.
Adolescent chest computed tomographies
Of 52 adolescents, 46 underwent chest CT. Of these, 80% had at least one CT abnormality: 22 (48%) had mosaic attenuation, 10 (22%) groundglass opacities, 9 (20%) bronchial wall thickening, 8 (17%) micronodules, 5 (11%) emphysema, and 4 (9%) bronchiectasis. Mosaic attenuation correlated with postbronchodilator airflow limitation (r ¼ 0.6, P ¼ 0.02); emphysema correlated with FEV 1 less than LLN (r ¼ 0.7, P ¼ 0.02). No other correlations between spirometry and CT abnormalities were detected.
Discussion
Adolescents had a disproportionately high prevalence of abnormal spirometry, low oxygen saturation and respiratory symptoms compared with adults, despite nearly universal ART and immune reconstitution/preservation. Adolescent age was independently associated with increased risk of abnormal spirometry, particularly airflow limitation, adjusting for HIV-related variables, malnutrition, smoke exposures, and prior pulmonary tuberculosis. The direct comparison of adolescents and adults from a single cohort is a key strength of our study and supports that abnormal spirometry prevalence is greater in adolescents with perinatally acquired HIV compared with adults with behaviorally acquired HIV. These data suggest that exposure to heterogeneous factors during lung growth with concomitant HIV may contribute to greater CLD risk in adolescent compared with adult PLWH in sub-Saharan Africa [23] .
Pathophysiologic mechanisms of CLD among adolescents with perinatally acquired HIVare largely unknown. However, perinatal and early life insults are linked with impaired lung function and CLD throughout the lifespan in HIV-uninfected populations [24, 25] . Perinatal insults may alter epigenetic determinants with potential longterm implications, including changes in lung structure/ function [26] . Further, HIV, an independent risk factor for CLD [5, 6, 9, 15] , is implicated in epigenetic dysregulation [27] . These concurrent exposures may confer disparately greater CLD risk among adolescents who acquired HIV during critical periods of lung and immune development, though early ART initiation may mitigate this risk [14, 23] .
The physiologic and structural abnormalities identified in adolescents are consistent with obliterative bronchiolitis, a (41) 61 (18) <0.001 Self-reported history of obstructive lung disease (asthma or COPD), n (%) 29 (7) 2 (4) 27 (7) 0.6 11 (13) 18 (5) 0.01
Low BMI b , n (%) 32 (7) 12 (23) 20 (5 þ <200 cells/ml, n (%)
46 (11) 3 (7) 43 (12) 0.5 11 (14) 35 (11) recently recognized cause of CLD among adolescents with perinatally acquired HIV in LMICs [11] . Adolescents, nearly all of whom acquired HIV perinatally in our cohort, had a high burden of abnormal spirometry, particularly airflow limitation that did not improve postbronchodilator. They frequently had abnormal CTs, with a predominance of mosaic attenuation that correlated with postbronchodilator airflow limitation but not bronchodilator responsiveness. These findings together argue against asthma as a primary CLD cause in this population, although asthma likely plays a role [11] [12] [13] 15, 22] . Although emphysema and bronchiectasis were rare, emphysema correlated with FEV 1 less than LLN (an indicator of impaired airflow). CLD characterization is critical for guiding management.
Prior pulmonary tuberculosis was an important cofactor for abnormal spirometry, in line with findings from other African studies [9, 15, 28] . Lung infections, including tuberculosis, may be in the causal pathway by which HIV augments risk for abnormal spirometry through airway and/or parenchymal destruction [28] [29] [30] . Three-quarters of individuals with HIV-associated tuberculosis live in sub-Saharan Africa and the burden of CLD associated with tuberculosis is anticipated to grow as PLWH age, pointing to opportunities to improve outcomes through integration of HIVand tuberculosis programmatic efforts.
Indoor kerosene use was also associated with abnormal spirometry, including FEV 1 less than LLN. The impact of household air pollution on lung health is a recognized contributor to mortality, and is associated with impaired lung function, CLD, and pneumonia, especially in LMICs [3, [31] [32] [33] . Although considered a cleaner alternative to biofuels, kerosene combustion emits more volatile organic compounds, which may explain its link to airflow limitation, tuberculosis, and pediatric pneumonia [3, 31, [34] [35] [36] .
Not unexpectedly, greater pack-years were associated with a higher risk of airflow limitation despite low smoking intensity and prevalence [3, 37, 38] . Gaining popularity, cigarette smoking is positioned to emerge as an important contributor to CLD in LMICs [38] [39] [40] .
Smoking prevention and cessation are essential.
Low BMI was associated with FVC less than LLN, as considered a marker of restricted spirometry. Although this finding may be influenced by differing definitions of low BMI in adolescents and adults, malnutrition has been linked with abnormal spirometry patterns [9, [41] [42] [43] .
Children living with HIV have a high risk of malnutrition, and those with CLD experience a 20-30% increase in nutritional needs [43, 44] . These unmet needs may persist into adolescence, perpetuating malnutrition, and CLD risk.
Our study has several limitations. We lacked an HIVuninfected comparison group. We may have misclassified a few adolescents as having perinatally acquired HIV, but the male:female ratio was nearly 1 : 1 in adolescents and 1 : 2 in adults, consistent with perinatally and behaviorally acquired HIV, respectively. Exposures/cofactors were ascertained by self-report, and CTs were interpreted using visual assessment by one radiologist. Finally, population size and outcome events may have provided insufficient statistical power to detect some associations.
In conclusion, adolescent age is an independent risk factor for abnormal spirometry, particularly airflow limitation, among PLWH, suggesting that adolescents with perinatally acquired HIV represent a unique group at risk for CLD [11] [12] [13] [14] [15] 23] . As more children with perinatally acquired HIV survive into adolescence in LMICs [45] , it is imperative to understand CLD pathophysiology across the lifespan of PLWH, and to improve strategies to mitigate the growing CLD burden.
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